Parexel Launches ParexelAI to Speed Up Clinical Development
Parexel launches ParexelAI, a proprietary Artificial Intelligence (AI) platform designed to accelerate clinical development by improving trial speed, efficiency, and data quality for sponsors and patients.
Parexel | 20/05/2026 | By News Bureau | 110
Parexel Acquires Vitrana to Boost Patient Safety Solutions
Parexel acquires Vitrana to enhance patient safety solutions with an Artificial Intelligence (AI)-enabled platform offering integrated pharmacovigilance, improved efficiency, and stronger regulatory compliance.
Parexel | 01/05/2026 | By News Bureau
Parexel Names Jim Anthony Chief Commercial Officer and President, Biotech Division
Parexel, a leading global clinical research organization (CRO), has appointed Jim Anthony as chief commercial officer (CCO) and president of Parexel Biotech, expanding his responsibilities to strengthen the company’s customer focus and accelerate growth.
Parexel | 22/08/2025 | By Darshana | 208
Parexel Join Hands with Palantir to Boost Clinical Data Delivery for Patients
Parexel has forged a multi-year strategic partnership with Palantir Technologies Inc. to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers.
Parexel | 29/04/2024 | By Aishwarya | 1288
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy